Calidi Biotherapeutics
CLDI
CLDI
12 hedge funds and large institutions have $3.54M invested in Calidi Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
91% less capital invested
Capital invested by funds: $40.6M → $3.54M (-$37.1M)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.44M | |
| 2 | +$416K | |
| 3 | +$277K | |
| 4 |
RWI
Red Wave Investments
Dillsburg,
Pennsylvania
|
+$188K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$101K |
Top Sellers
| 1 | -$5.25M | |
| 2 | -$4.2M | |
| 3 | -$3.74M | |
| 4 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$3.2M |
| 5 |
6CM
683 Capital Management
New York
|
-$3.15M |